Liabilities / Assets
28th percentile
Higher debt load relative to assets than 28% of similar nonprofits.
Frontiers in Bioscience Inc.
990 • Fiscal year 2024 • EIN 59-3432665
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.03x
Liabilities / Revenue
89th percentile
Higher debt load relative to revenue than 89% of similar nonprofits.
Net Margin
3rd percentile
Higher net margin than 3% of similar nonprofits.
Top Officer Pay
22nd percentile
Higher top officer pay than 22% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
34th percentile
Faster asset growth than 34% of similar nonprofits.
Revenue Growth
7th percentile
Faster revenue growth than 7% of similar nonprofits.
Balance Sheet
Assets
Up$9,147,259
Up $14,397 (+0.2%) from 2023
Net Assets
Up$8,903,211
Up $22,421 (+0.3%) from 2023
Liabilities
Down$244,048
Down $8,024 (-3.2%) from 2023
Revenue And Expenses
Revenue
Down$159,183
Down $93,648 (-37%) from 2023
Expenses
Up$334,551
Up $69,907 (+26%) from 2023
Net Income
Down-$175,368
Down $163,555 (-1385%) from 2023
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2024 to Dec 31, 2024
- Signed
- Apr 24, 2025
- Return Version
- 2024v5.0
- Gross Receipts
- $308,135
Mission and Program Overview
Mission
Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.
Balance Sheet Detail
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Land, Buildings, and Equipment, Net | $5,673,830 | $5,810,376 | ▲ $136,546 |
| Savings and Temporary Cash Investments | $3,348,302 | $3,146,321 | ▼ $201,981 |
| Loans From Officers Directors | $233,187 | $233,187 | → $0 |
| Cash and Non-Interest-Bearing Accounts | $105,269 | $137,036 | ▲ $31,767 |
| Prepaid Expenses and Deferred Charges | - | $6,045 | - |
| Investments in Publicly Traded Securities | $5,461 | $5,481 | ▲ $20 |
| Total Assets | $9,174,862 | $9,147,259 | ▼ $27,603 |
| Other Assets Total | $42,000 | $42,000 | → $0 |
| Liabilities | |||
| Other Liabilities | $18,885 | $10,861 | ▼ $8,024 |
| Total Liabilities | $252,072 | $244,048 | ▼ $8,024 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $8,922,790 | $8,903,211 | ▼ $19,579 |
| Total Net Assets Fund Balance | $8,922,790 | $8,903,211 | ▼ $19,579 |
| Total Liabilities and Net Assets / Fund Balance | $9,174,862 | $9,147,259 | ▼ $27,603 |
Asset Categories
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Buildings | $2,556,110 | $947,043 | $3,503,153 |
| Land | $3,229,805 | - | $3,229,805 |
| Other Land Buildings | $27,461 | $387,080 | $414,541 |
Compensation and Service Providers
Board Members and Trustees
| Name | Title |
|---|---|
| Siamak Tabibzadeh Md | CEO |
| Shila Roofim | CFO |
| Forough Sooferian | Sec |
Revenue and Support
Revenue Composition
- Contributions and Grants
- $0
- Program Service Revenue
- $0
- Investment Income
- $2,882
- Other Revenue
- $156,301
- Change in Net Assets
- $-175,368
Expenses and Functional Allocation
Major Expense Lines
| Line Item | Amount |
|---|---|
| Salaries, Compensation, and Employee Benefits | $181,483 |
| Other Expenses | $153,068 |
| Total Fundraising Expense | $9,639 |
| Grants and Similar Amounts Paid | $0 |
| Professional Fundraising Fees | $0 |
Functional Expense Allocation
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Comp Disqual Persons | $70,400 | $8,800 | $8,800 | $88,000 |
| Other Salaries and Wages | $80,085 | - | - | $80,085 |
| Depreciation Depletion | $50,166 | - | - | $50,166 |
| All Other Expenses | $14,324 | $17,320 | - | $31,644 |
| Payroll Taxes | $11,720 | $839 | $839 | $13,398 |
| Other Expenses | $15,723 | $13,036 | - | $13,036 |
| Fees for Services Accounting | $3,285 | - | - | $3,285 |
| Insurance | $-337 | - | - | $-337 |
| Total Functional Expenses | $284,917 | $39,995 | $9,639 | $334,551 |
Fundraising, Events, and Gaming
- Fundraising activities
- No
- Gaming activities
- No
- Professional fundraiser used
- No
Fundraising and Gaming Totals
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
Political and Lobbying Activity
- Political campaign activity
- No
- Lobbying activity
- No
- Subject to proxy tax
- No
Insider Transactions and Loans
Loans and Receivables
| Line Item | Beginning | End | Change |
|---|---|---|---|
| Loans from Officers, Directors, Trustees, and Key Employees | $233,187 | $233,187 | → $0 |
Debt and Bond Financing
Other Reported Liabilities
| Liability | Amount |
|---|---|
| Tenant Deposits | $8,290 |
| Credit Card/ Payroll Taxes | $2,571 |
Governance and Compliance
Governance Checklist
- Compiled or reviewed by an accountant
- No
- Backup withholding compliance
- No
- Business relationship with 35% controlled entity
- No
- Business relationship with family members
- No
- Business relationship with organization members
- No
- Material changes to governing documents
- No
- Compensation from other sources disclosed
- No
- CEO compensation reviewed
- No
- Other officer compensation reviewed
- No
- Conflict-of-interest policy
- No
- Audited financial statements prepared
- No
- Key decisions subject to board approval
- No
- Management duties delegated
- No
Governance Explanations
Form 990, Page 6, Part VI, Line 11B
“No review was or will be conducted.”
Form 990, Page 6, Part VI, Line 19
“No documents available to the public”
Filing and Contact Details
Filer
- Filer Name
- Frontiers in Bioscience
- EIN
- 59-3432665
- Phone
- 9497158286
- Address
- 20 SUNSET COVE, NEWPORT COAST, CA 92657
Signing Officer
- Name
- Siamak Tabibzadeh Md
- Title
- CEO
- Phone
- 9497158286
- Signed
- 2025-04-24
- Discuss with paid preparer
- Yes
Organization Details
- Principal Officer
- Siamak Tabibzadeh Md
- Voting Board Members
- 3
- Independent Board Members
- 0
- Employees
- 3
Preparer
- Firm
- Lgh Consulting Inc
- Address
- 585 S STATE COLLEGE BLVD, ANAHEIM, CA 92806-4222
- Preparer
- George Hukriede
- Phone
- 7148089170
Supplemental Narrative
Additional Explanations
FORM 990 - ORGANIZATION'S MISSION
“Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.”
Form 990
“See attachment november 20, 2022 part iv, line 63, loans from officers, director and employee on november 20, 2002, frontiers in bioscience, inc. Purchased for investment purposes only residential real estate located at 67 parkview drive, searingtown, new york. In connection with the organization's purchase of said real estate, frontiers in bioscience inc., incurred a mortgage payable with the presiden and founder, siamak tabibzadeh, md, in the amount of 145,000 lender's name: siamak tabibzadeh, md original amount of note: 154,000 balance due: 145,555 date of note: november 20, 2002 maturity date: open, see below repayment terms: principal and accrued interest due upon sale of property interest rete: rate of 4.5% per annum, principal and interest due upon sale of property or at such time as the board of director determines that there are sufficient operating funds to retire the obiligation security priovided by the borrower: mortgage note secured by real estate located at 67 parkview drive, searingtown, ny 11507 purpose of the loan: to be able to purchase real estate at below fair market value to see in no longer than two operating cycles in order to obtain sufficient funding to endow a full time medical researcher and editor. Interst calcuation original amount of principal: 154,000 from to interest amount (rate, 4.5%) - principal + interest nov 20, 2002 154,000 nov 20, 2002 nov 20, 2003 6,930 - 160,930 - 15,375 removed principal & interest leaving 145,555 nov 20, 2003 nov 20, 2004 6,549 - 152,104 nov 20, 2004 nov 20, 2005 6,844 - 158,948 nov 20, 2005 nov 20, 2006 7,152 - 166,100 nov 20, 2006 nov 20, 2007 7,474 - 173,574 nov 20, 2007 nov 20, 2008 7,810 - 181,384 nov 20, 2008 nov 20, 2009 8,162 - 189,546 nov 20, 2009 nov 20, 2010 8,529 - 198,075 nov 20, 2010 nov 20, 2011 8,913 - 206,988 nov 20, 2011 nov 20, 2012 9,314 - 216,302 nov 20, 2012 nov 20, 2013 9,733 - 226,035 nov 20, 2013 nov 20, 2014 10,171 - 236,206 nov 20, 2014 nov 20, 2015 10,629 - 257,942 nov 20, 2015 nov 20, 2016 11,107 - 246,835 nov 20, 2016 nov 20, 2017 11,607 - 269,549 principal paid 269,549-145,555=123,994 nov 20, 2017 nov 20, 2018 5,579 - 129,573 nov 20, 2018 nov 20, 2019 5,830 - 135,403 nov 20, 2019 nov 20, 2020 6,093 - 141,496 nov 20, 2020 nov 20, 2021 6,367 - 147,863 nov 20, 2021 nov 20, 2022 6,653 - 154,516 to correct funds for investment 11/30/03 78,671- 233187”
Form 990, Part XI, Line 9
“Book / tax depreciation difference 18,533”
Raw XML Appendix354 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. |
| IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt | 0 | 17320 |
| IRS990/AllOtherExpensesGrp/ProgramServicesAmt | 0 | 14324 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 31644 |
| IRS990/BackupWthldComplianceInd | 0 | false |
| IRS990/BooksInCareOfDetail/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 9497158286 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | NEWPORT COAST |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92657 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | false |
| IRS990/BusinessRlnWithFamMemInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | false |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 105269 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 137036 |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompDisqualPersonsGrp/FundraisingAmt | 0 | 8800 |
| IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt | 0 | 8800 |
| IRS990/CompDisqualPersonsGrp/ProgramServicesAmt | 0 | 70400 |
| IRS990/CompDisqualPersonsGrp/TotalAmt | 0 | 88000 |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | false |
| IRS990/CompensationProcessOtherInd | 0 | false |
| IRS990/ConflictOfInterestPolicyInd | 0 | false |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 0 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 0 |
| IRS990/CYInvestmentIncomeAmt | 0 | 2882 |
| IRS990/CYOtherExpensesAmt | 0 | 153068 |
| IRS990/CYOtherRevenueAmt | 0 | 156301 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -175368 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 181483 |
| IRS990/CYTotalExpensesAmt | 0 | 334551 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 9639 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 159183 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/DepreciationDepletionGrp/ProgramServicesAmt | 0 | 50166 |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 50166 |
| IRS990/Desc | 0 | FOSTERING SCIENCE, RESEARCH AND TEACHING IN THE AREAS OF MEDICINE, BIOLOGY,CANCER AND AGING. |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | false |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | false |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 3 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | false |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 284917 |
| IRS990/FamilyOrBusinessRlnInd | 0 | false |
| IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt | 0 | 3285 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 3285 |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | SHILA ROOFIM |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | FOROUGH SOOFERIAN |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | CEO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | CFO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | SEC |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | false |
| IRS990/Form990TFiledInd | 0 | true |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedInd | 0 | false |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 3 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | false |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossReceiptsAmt | 0 | 308135 |
| IRS990/GrossRentsGrp/RealAmt | 0 | 302441 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | false |
| IRS990/IndependentAuditFinclStmtInd | 0 | false |
| IRS990/IndependentVotingMemberCnt | 0 | 0 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIInd | 0 | X |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | -337 |
| IRS990/InsuranceGrp/TotalAmt | 0 | -337 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 24 |
| IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt | 0 | 2858 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 2882 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/InvestmentsPubTradedSecGrp/BOYAmt | 0 | 5461 |
| IRS990/InvestmentsPubTradedSecGrp/EOYAmt | 0 | 5481 |
| IRS990/IRPDocumentCnt | 0 | 3 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 1337123 |
| IRS990/LandBldgEquipBasisNetGrp/BOYAmt | 0 | 5673830 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 5810376 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 7147499 |
| IRS990/LessRentalExpensesGrp/RealAmt | 0 | 148952 |
| IRS990/LoanOutstandingInd | 0 | true |
| IRS990/LoansFromOfficersDirectorsGrp/BOYAmt | 0 | 233187 |
| IRS990/LoansFromOfficersDirectorsGrp/EOYAmt | 0 | 233187 |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 8922790 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 8903211 |
| IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt | 0 | 153489 |
| IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt | 0 | 153489 |
| IRS990/NetUnrelatedBusTxblIncmAmt | 0 | 152495 |
| IRS990/NetUnrlzdGainsLossesInvstAmt | 0 | 155789 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 8922790 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 8903211 |
| IRS990/NoListedPersonsCompensatedInd | 0 | X |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 42000 |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 42000 |
| IRS990/OtherExpensesGrp/Desc | 0 | PROPERTY TAXES |
| IRS990/OtherExpensesGrp/Desc | 1 | OPERATING SUPPLIES |
| IRS990/OtherExpensesGrp/Desc | 2 | LAB SUPPLIES |
| IRS990/OtherExpensesGrp/Desc | 3 | UTILITIES |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 0 | 13036 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 22414 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 17137 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 2 | 15723 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 22414 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 17137 |
| IRS990/OtherExpensesGrp/TotalAmt | 2 | 15723 |
| IRS990/OtherExpensesGrp/TotalAmt | 3 | 13036 |
| IRS990/OtherLiabilitiesGrp/BOYAmt | 0 | 18885 |
| IRS990/OtherLiabilitiesGrp/EOYAmt | 0 | 10861 |
| IRS990/OtherRevenueMiscGrp/BusinessCd | 0 | 900099 |
| IRS990/OtherRevenueMiscGrp/Desc | 0 | MISC |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 0 | 6 |
| IRS990/OtherRevenueMiscGrp/UnrelatedBusinessRevenueAmt | 0 | 6 |
| IRS990/OtherRevenueTotalAmt | 0 | 6 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 80085 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 80085 |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PayrollTaxesGrp/FundraisingAmt | 0 | 839 |
| IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt | 0 | 839 |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 11720 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 13398 |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt | 0 | 6045 |
| IRS990/PrincipalOfficerNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYContributionsGrantsAmt | 0 | 9394 |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/PYInvestmentIncomeAmt | 0 | 152090 |
| IRS990/PYOtherExpensesAmt | 0 | 115873 |
| IRS990/PYOtherRevenueAmt | 0 | 91347 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | -11813 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 148771 |
| IRS990/PYTotalExpensesAmt | 0 | 264644 |
| IRS990/PYTotalRevenueAmt | 0 | 252831 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | -175368 |
| IRS990/RelatedEntityInd | 0 | false |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/RentalIncomeOrLossGrp/RealAmt | 0 | 153489 |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | true |
| IRS990/ReportOtherAssetsInd | 0 | false |
| IRS990/ReportOtherLiabilitiesInd | 0 | true |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 2806 |
| IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt | 0 | 2806 |
| IRS990/SavingsAndTempCashInvstGrp/BOYAmt | 0 | 3348302 |
| IRS990/SavingsAndTempCashInvstGrp/EOYAmt | 0 | 3146321 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 9394 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 9394 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt | 0 | 24 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt | 0 | 486 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 27615 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 8428 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 36553 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 5664 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 155032 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 147977 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 286789 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 595462 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt | 0 | 24 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt | 0 | 486 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt | 0 | 27615 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt | 0 | 8428 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 36553 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.04000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.05000 |
| IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearAmt | 0 | 152495 |
| IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus1YearAmt | 0 | 86919 |
| IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus4YearsAmt | 0 | 17915 |
| IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt | 0 | 257329 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.67300 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.80910 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 604856 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 5664 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 164426 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 147977 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 286789 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 604856 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 158183 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 251831 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 175592 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 295217 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 17915 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 898738 |
| IRS990/ScheduleBRequiredInd | 0 | false |
| IRS990ScheduleD/BuildingsGrp/BookValueAmt | 0 | 2556110 |
| IRS990ScheduleD/BuildingsGrp/DepreciationAmt | 0 | 947043 |
| IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt | 0 | 3503153 |
| IRS990ScheduleD/LandGrp/BookValueAmt | 0 | 3229805 |
| IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt | 0 | 3229805 |
| IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt | 0 | 27461 |
| IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt | 0 | 387080 |
| IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt | 0 | 414541 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt | 0 | 8290 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt | 1 | 2571 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc | 0 | TENANT DEPOSITS |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc | 1 | CREDIT CARD/ PAYROLL TAXES |
| IRS990ScheduleD/TotalBookValueLandBuildingsAmt | 0 | 5813376 |
| IRS990ScheduleD/TotalLiabilityAmt | 0 | 10861 |
| IRS990/ScheduleJRequiredInd | 0 | false |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt | 0 | 233187 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd | 0 | true |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd | 0 | false |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt | 0 | TO AID THE ORGAN TO ACQUIRED INVEST |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd | 0 | X |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt | 0 | 154000 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt | 0 | DIRECTOR |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd | 0 | true |
| IRS990ScheduleL/TotalBalanceDueAmt | 0 | 233187 |
| IRS990/ScheduleORequiredInd | 0 | false |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | SEE ATTACHMENT NOVEMBER 20, 2022 PART IV, LINE 63, LOANS FROM OFFICERS, DIRECTOR AND EMPLOYEE ON NOVEMBER 20, 2002, FRONTIERS IN BIOSCIENCE, INC. PURCHASED FOR INVESTMENT PURPOSES ONLY RESIDENTIAL REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NEW YORK. IN CONNECTION WITH THE ORGANIZATION'S PURCHASE OF SAID REAL ESTATE, FRONTIERS IN BIOSCIENCE INC., INCURRED A MORTGAGE PAYABLE WITH THE PRESIDEN AND FOUNDER, SIAMAK TABIBZADEH, MD, IN THE AMOUNT OF 145,000 LENDER'S NAME: SIAMAK TABIBZADEH, MD ORIGINAL AMOUNT OF NOTE: 154,000 BALANCE DUE: 145,555 DATE OF NOTE: NOVEMBER 20, 2002 MATURITY DATE: OPEN, SEE BELOW REPAYMENT TERMS: PRINCIPAL AND ACCRUED INTEREST DUE UPON SALE OF PROPERTY INTEREST RETE: RATE OF 4.5% PER ANNUM, PRINCIPAL AND INTEREST DUE UPON SALE OF PROPERTY OR AT SUCH TIME AS THE BOARD OF DIRECTOR DETERMINES THAT THERE ARE SUFFICIENT OPERATING FUNDS TO RETIRE THE OBILIGATION SECURITY PRIOVIDED BY THE BORROWER: MORTGAGE NOTE SECURED BY REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NY 11507 PURPOSE OF THE LOAN: TO BE ABLE TO PURCHASE REAL ESTATE AT BELOW FAIR MARKET VALUE TO SEE IN NO LONGER THAN TWO OPERATING CYCLES IN ORDER TO OBTAIN SUFFICIENT FUNDING TO ENDOW A FULL TIME MEDICAL RESEARCHER AND EDITOR. INTERST CALCUATION ORIGINAL AMOUNT OF PRINCIPAL: 154,000 FROM TO INTEREST AMOUNT (RATE, 4.5%) - PRINCIPAL + INTEREST NOV 20, 2002 154,000 NOV 20, 2002 NOV 20, 2003 6,930 - 160,930 - 15,375 REMOVED PRINCIPAL & INTEREST LEAVING 145,555 NOV 20, 2003 NOV 20, 2004 6,549 - 152,104 NOV 20, 2004 NOV 20, 2005 6,844 - 158,948 NOV 20, 2005 NOV 20, 2006 7,152 - 166,100 NOV 20, 2006 NOV 20, 2007 7,474 - 173,574 NOV 20, 2007 NOV 20, 2008 7,810 - 181,384 NOV 20, 2008 NOV 20, 2009 8,162 - 189,546 NOV 20, 2009 NOV 20, 2010 8,529 - 198,075 NOV 20, 2010 NOV 20, 2011 8,913 - 206,988 NOV 20, 2011 NOV 20, 2012 9,314 - 216,302 NOV 20, 2012 NOV 20, 2013 9,733 - 226,035 NOV 20, 2013 NOV 20, 2014 10,171 - 236,206 NOV 20, 2014 NOV 20, 2015 10,629 - 257,942 NOV 20, 2015 NOV 20, 2016 11,107 - 246,835 NOV 20, 2016 NOV 20, 2017 11,607 - 269,549 PRINCIPAL PAID 269,549-145,555=123,994 NOV 20, 2017 NOV 20, 2018 5,579 - 129,573 NOV 20, 2018 NOV 20, 2019 5,830 - 135,403 NOV 20, 2019 NOV 20, 2020 6,093 - 141,496 NOV 20, 2020 NOV 20, 2021 6,367 - 147,863 NOV 20, 2021 NOV 20, 2022 6,653 - 154,516 TO CORRECT FUNDS FOR INVESTMENT 11/30/03 78,671- 233187 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | NO REVIEW WAS OR WILL BE CONDUCTED. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | NO DOCUMENTS AVAILABLE TO THE PUBLIC |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | BOOK / TAX DEPRECIATION DIFFERENCE 18,533 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990 - ORGANIZATION'S MISSION |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PAGE 6, PART VI, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PAGE 6, PART VI, LINE 19 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PART XI, LINE 9 |
| IRS990/SchoolOperatingInd | 0 | false |
| IRS990/SignificantChangeInd | 0 | false |
| IRS990/SignificantNewProgramSrvcInd | 0 | false |
| IRS990/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990/SubjectToExcsTaxNetInvstIncInd | 0 | false |
| IRS990/SubjectToProxyTaxInd | 0 | false |
| IRS990/SubjToTaxRmnrtnExPrchtPymtInd | 0 | false |
| IRS990/TaxablePartyNotificationInd | 0 | false |
| IRS990/TaxExemptBondsInd | 0 | false |
| IRS990/TerminateOperationsInd | 0 | false |
| IRS990/TotalAssetsBOYAmt | 0 | 9174862 |
| IRS990/TotalAssetsEOYAmt | 0 | 9147259 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 9174862 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 9147259 |
| IRS990/TotalCompGreaterThan150KInd | 0 | false |
| IRS990/TotalEmployeeCnt | 0 | 3 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 9639 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 39995 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 284917 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 334551 |
| IRS990/TotalGrossUBIAmt | 0 | 153495 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 252072 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 244048 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 252072 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 244048 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 8922790 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 8903211 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 284917 |
| IRS990/TotalRevenueGrp/ExclusionAmt | 0 | 24 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 5664 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 159183 |
| IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt | 0 | 153495 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 9174862 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 9147259 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990/TypeOfOrganizationCorpInd | 0 | X |
| IRS990/UnrelatedBusIncmOverLimitInd | 0 | true |
| IRS990/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| IRS990/USAddress/CityNm | 0 | NEWPORT COAST |
| IRS990/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/USAddress/ZIPCd | 0 | 92657 |
| IRS990/VotingMembersGoverningBodyCnt | 0 | 3 |
| IRS990/VotingMembersIndependentCnt | 0 | 0 |
| IRS990/WebsiteAddressTxt | 0 | WWW.BIOSCIENCE.ORG |
| IRS990/WhistleblowerPolicyInd | 0 | false |
| ReturnHeader/BuildTS | 0 | 2025-03-06 01:10:19Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | CEO |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 9497158286 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2025-04-24 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | FRONTIERS IN BIOSCIENCE |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | FRON |
| ReturnHeader/Filer/EIN | 0 | 593432665 |
| ReturnHeader/Filer/PhoneNum | 0 | 9497158286 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | NEWPORT COAST |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92657 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | false |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 330990695 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | LGH CONSULTING INC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 585 S STATE COLLEGE BLVD |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | ANAHEIM |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 928064222 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 7148089170 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2025-04-29 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | GEORGE HUKRIEDE |
| ReturnHeader/ReturnTs | 0 | 2025-04-29T14:11:22-04:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990 |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2024-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2024-12-31 |
| ReturnHeader/TaxYr | 0 | 2024 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2024 • Form 990Detailed filing. Detailed filing data is available for this year.
- Assets
- $9,147,259
- Liabilities
- $244,048
- Net assets
- $8,903,211
- Revenue
- $159,183
- Expenses
- $334,551
- Net income
- -$175,368